BAFNA PHARMACEUTICALS
Back to Cashflow Statement
|
BAFNA PHARMACEUTICALS Last 5 Year Net Cash Inflow / Outflow History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹-6.41 Cr | ₹7.64 Cr | ₹-1.63 Cr | ₹-6.68 Cr | ₹5.78 Cr |
What is the latest Net Cash Inflow / Outflow ratio of BAFNA PHARMACEUTICALS ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹-6.41 Cr |
Mar2023 | ₹7.64 Cr |
Mar2022 | ₹-1.63 Cr |
Mar2021 | ₹-6.68 Cr |
Mar2020 | ₹5.78 Cr |
How is Net Cash Inflow / Outflow of BAFNA PHARMACEUTICALS Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹-6.41 Cr | Negative | |
Mar2023 | ₹7.64 Cr | Positive | |
Mar2022 | ₹-1.63 Cr | Negative | |
Mar2021 | ₹-6.68 Cr | Negative | |
Mar2020 | ₹5.78 Cr | - |
Compare Net Cash Inflow / Outflow of peers of BAFNA PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BAFNA PHARMACEUTICALS | ₹176.6 Cr | -2.7% | -0.5% | -27.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹404,588.0 Cr | -7.3% | 1.1% | 15.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,711.0 Cr | -3.5% | 12.9% | 53.4% | Stock Analytics | |
CIPLA | ₹122,115.0 Cr | 0.1% | 9.2% | 6.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,589.0 Cr | -1% | 0.2% | 19.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,746.6 Cr | 3.1% | 9.8% | -7.6% | Stock Analytics |
BAFNA PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BAFNA PHARMACEUTICALS | -2.7% |
-0.5% |
-27.2% |
SENSEX | 2% |
9.4% |
11.6% |
You may also like the below Video Courses